Zobrazeno 1 - 10
of 126
pro vyhledávání: '"Hirofumi Ota"'
Autor:
Manabu Shiozawa, Yu Sunakawa, Takanori Watanabe, Hirofumi Ota, Hisateru Yasui, Taichi Yabuno, Mitsuyoshi Tei, Mitsugu Kochi, Dai Manaka, Hisatsugu Ohori, Tatsuro Yamaguchi, Tamotsu Sagawa, Masahito Kotaka, Yutaro Kubota, Takashi Sekikawa, Masato Nakamura, Masahiro Takeuchi, Wataru Ichikawa, Masashi Fujii, Akihito Tsuji
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-9 (2024)
Abstract The clinical significance of FOLFOXIRI (5-FU, leucovorin, oxaliplatin, and irinotecan) plus anti-EGFR monoclonal antibody using cetuximab for metastatic colorectal cancer (mCRC) remains controversial. We report results from a randomized phas
Externí odkaz:
https://doaj.org/article/c5c30590bce046fe8b38d53091cad924
Autor:
Taishi Hata, Mamoru Uemura, Katsuki Danno, Shinichi Yoshioka, Chu Matsuda, Yoshinori Kagawa, Tatsushi Shingai, Yozo Suzuki, Mitsuyoshi Tei, Tsukasa Tanida, Takamichi Komori, Shu Okamura, Hirofumi Ota, Hiroyoshi Takemoto, Takayuki Ogino, Norikatsu Miyoshi, Hirofumi Yamamoto, Kohei Murata, Yuichiro Doki, Hidetoshi Eguchi
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract Adjuvant oxaliplatin plus capecitabine (XELOX) therapy is recommended for patients with curatively resected colon cancer. However, prospective data on its practical application in Japanese patients are limited. Therefore, we aimed to conduct
Externí odkaz:
https://doaj.org/article/8397edc0e89c4d1c838969c4c7173351
Autor:
Hirofumi OTA
Publikováno v:
AAOS Transactions, Vol 12, Iss 1, Pp 14-27 (2023)
How did a company exposed to a harsh business environment embody ambidextrous management and result in fundamental restructuring of management in trouble? This article aimed at unveiling from interviews with executives qualitatively the ambidextrous
Externí odkaz:
https://doaj.org/article/54e2a059bf2649d0aff3dcb155ea4ebb
Autor:
Hirofumi OTA
Publikováno v:
AAOS Transactions, Vol 12, Iss 1, Pp 1-13 (2023)
抄録 What is the source of competitiveness of MonotaRO Co., Ltd. （MonotaRO）, the largest EC company for industrial MRO? This paper aimed at unveiling the business strategy of this company from the point of view of three Winner-Take-All （WT
Externí odkaz:
https://doaj.org/article/d9093fecb28643ffbc37abdbec5c964b
An evaluation of rehabilitation students’ learning goals in their first year: a text mining approach
Autor:
Shin Kitamura, Kotaro Takeda, Shintaro Uehara, Taiki Yoshida, Hirofumi Ota, Shigeo Tanabe, Kazuya Takeda, Soichiro Koyama, Hiroaki Sakurai, Yoshikiyo Kanada
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
IntroductionQualitative information in the form of written reflection reports is vital for evaluating students’ progress in education. As a pilot study, we used text mining, which analyzes qualitative information with quantitative features, to inve
Externí odkaz:
https://doaj.org/article/8dcfdf7ff3354f68a6eacbfa63dfb538
Autor:
Hirofumi Ota, Masahiko Mukaino, Yukari Inoue, Shoh Matsuura, Senju Yagi, Yoshikiyo Kanada, Eiichi Saitoh, Yohei Otaka
Publikováno v:
JMIR Rehabilitation and Assistive Technologies, Vol 10, p e50571 (2023)
BackgroundUpper limb motor paresis is a major symptom of stroke, which limits activities of daily living and compromises the quality of life. Kinematic analysis offers an in-depth and objective means to evaluate poststroke upper limb paresis, with an
Externí odkaz:
https://doaj.org/article/37c944e7c7a44f3bb9c9a435762910ad
Autor:
Takeshi Kato, Toshihiro Kudo, Yoshinori Kagawa, Kohei Murata, Hirofumi Ota, Shingo Noura, Junichi Hasegawa, Hiroshi Tamagawa, Katsuya Ohta, Masakazu Ikenaga, Susumu Miyazaki, Takamichi Komori, Mamoru Uemura, Junichi Nishimura, Taishi Hata, Chu Matsuda, Taroh Satoh, Tsunekazu Mizushima, Yuko Ohno, Hirofumi Yamamoto, Yuichiro Doki, Hidetoshi Eguchi
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Regorafenib has shown significant survival benefit as a salvage therapy for colorectal cancer; however, its starting dose has been controversial in recent studies. Therefore, we conducted a prospective study on the efficacy and safety of the
Externí odkaz:
https://doaj.org/article/9bbabfbd9acf414bb4f4b4ff00be6559
Autor:
Akiko Maeda, Megumi Suzuki, Toshio Teranishi, Mihoko Ito, Nozomi Hokimoto, Kenta Fujimura, Hirofumi Ota, Eiichi Saitoh
Publikováno v:
Fujita Medical Journal, Vol 7, Iss 1, Pp 8-11 (2021)
Objectives: This study sought to determine whether therapists experience more accidents annually with increased clinical experience, and whether experiencing an accident in the first year of practice is associated with accidents in the second year of
Externí odkaz:
https://doaj.org/article/57dcf0347f1646a8a467649480fb6f9f
Autor:
Hirofumi Ota, Katsuki Danno, Katsuya Ohta, Tae Matsumura, Takamichi Komori, Shu Okamura, Miho Okano, Atsuhiro Ogawa, Hiroshi Tamagawa, Mamoru Uemura, Chu Matsuda, Tsunekazu Mizushima, Hirofumi Yamamoto, Riichiro Nezu, Yuichiro Doki, Hidetoshi Eguchi
Publikováno v:
Journal of the Anus, Rectum and Colon, Vol 4, Iss 3, Pp 114-121 (2020)
Objectives: The efficacy of negative pressure wound therapy (NPWT) and its application to severely contaminated wounds sustained during surgery remain to be established. Here, we evaluated the efficacy of utilizing NPWT until delayed primary closure
Externí odkaz:
https://doaj.org/article/765be93c8cb14f6083936ddbd4abd7da
Autor:
Toshinori Sueda, Kohei Murata, Takashi Takeda, Yoshinori Kagawa, Junichi Hasegawa, Takamichi Komori, Shingo Noura, Kimimasa Ikeda, Masaki Tsujie, Masayuki Ohue, Hirofumi Ota, Masakazu Ikenaga, Taishi Hata, Chu Matsuda, Tsunekazu Mizushima, Hirofumi Yamamoto, Mitsugu Sekimoto, Riichiro Nezu, Masaki Mori, Yuichiro Doki
Publikováno v:
Annals of Gastroenterological Surgery, Vol 3, Iss 3, Pp 291-300 (2019)
Abstract Aim Appendiceal mucinous neoplasms are rare, and thus the literature is sparse with regard to histological types, staging, and prognosis. In particular, it is unclear how long‐term outcome may differ between mucinous adenocarcinomas and ot
Externí odkaz:
https://doaj.org/article/5b9e0f2c5b874e1199d78009153ec67d